FDA Should Consider New Lead Level Tests, Label Requirements – Advisers
This article was originally published in The Tan Sheet
Executive Summary
Drug and dietary supplement manufacturers may need to include lead information on labels and use more sensitive test methods for lead levels in products if FDA follows the suggestions of the Advisory Committee for Pharmaceutical Science and Clinical Pharmacology
You may also be interested in...
Call For Testing Metal Levels In Supplements Gets Mixed Reviews
Industry stakeholders differ on whether researchers are justified in recommending setting daily limits for toxic metals in dietary supplements
Call For Testing Metal Levels In Supplements Gets Mixed Reviews
Industry stakeholders differ on whether researchers are justified in recommending setting daily limits for toxic metals in dietary supplements
Call For Testing Metal Levels In Supplements Gets Mixed Reviews
Industry stakeholders differ on whether researchers are justified in recommending setting daily limits for toxic metals in dietary supplements